Reviewed by Michael R. · Last Updated September 22, 2026 · How we review
Honey’s use in modern wound care is not folk medicine; a small category of honey-based products is cleared by the FDA as medical devices and used in hospitals and wound clinics. But "honey helps wounds" is not the same claim as "honey is a proven treatment for every wound type," and the two get blurred constantly. This guide explains what medical-grade honey actually is, how it differs from raw honey, what the FDA clearance record actually says, and — using the primary trial and guideline documents rather than secondhand summaries — where the clinical evidence is genuinely strong and where it is not.
Disclaimer: This article is educational information about a medical device category, not medical advice, and it is not a substitute for evaluation by a qualified wound-care clinician. For the official U.S. regulatory record, see the FDA 510(k) database entry for Medihoney Primary Dressings (K072956).
On this page
- What Medical-Grade Honey Actually Is
- How It Differs From Raw Honey: Sterilization Matters
- FDA Clearance: What the Record Actually Shows
- What the Clinical Evidence Actually Shows
- Raw Honey vs. Medical-Grade Honey vs. Standard Dressings
- Why Honey Works: The Mechanism
- Where It’s Actually Used in Practice
- Where the Evidence Is Weaker or the Product Isn’t Appropriate
- Common Mistakes
- Frequently Asked Questions
Key Takeaways
- Medical-grade honey is a real, FDA-cleared wound-dressing category, genuinely different from raw honey because it is gamma-irradiated for sterility and standardized for antibacterial potency.
- The FDA clearance record (K072956, November 2007) lists the cleared indications as diabetic foot ulcers, venous/arterial/mixed-etiology leg ulcers, partial- and full-thickness pressure ulcers, 1st- and 2nd-degree partial-thickness burns, and donor-site, traumatic, and surgical wounds.
- The evidence is not uniformly strong. A 2018 Canadian guideline review (CADTH) recommends against honey for chronic wounds, including venous leg ulcers, and the largest randomized trial on record (368 patients) found no statistically significant healing benefit over usual care.
- Evidence is more supportive for partial-thickness burns, and honey dressings may be considered for pressure injuries per the same guideline review.
- It is a complementary antimicrobial option relevant to antibiotic-resistant infections, not a replacement for surgical debridement or systemic antibiotics when those are what a wound actually needs.
- Raw, unsterilized honey from a kitchen jar is not the same product and is not verified safe for open wounds.
Table of Contents
- What Medical-Grade Honey Actually Is
- How It Differs From Raw Honey: Sterilization Matters
- FDA Clearance: What the Record Actually Shows
- What the Clinical Evidence Actually Shows
- Raw Honey vs. Medical-Grade Honey vs. Standard Dressings
- Why Honey Works: The Mechanism
- Where It's Actually Used in Practice
- Where the Evidence Is Weaker or the Product Isn't Appropriate
- Common Mistakes
- Frequently Asked Questions
What Medical-Grade Honey Actually Is
Medical-grade honey is honey — most often Manuka honey — processed to a standardized, verified potency and sterilized specifically for topical wound care, sold as impregnated dressings, gels, and pastes for direct clinical application. Products like Medihoney, among the best-known brands in the category, are tested to a consistent level of antibacterial activity, typically measured by methylglyoxal (MGO) content in Manuka-based products, the same compound behind the UMF rating system covered in this site’s guide to Manuka honey and UMF ratings. That standardization, combined with sterilization, is what separates a cleared medical device from an ordinary jar of honey, even when both start from a similar floral source.
How It Differs From Raw Honey: Sterilization Matters
Raw honey, even good raw honey, is not sterile and can carry dormant bacterial spores, including Clostridium botulinum, the same organism behind the infant botulism risk covered in this site’s guide to whether honey is safe for babies. Those spores pose essentially no risk to a healthy adult gut, but an open wound is a different exposure route entirely — it bypasses the digestive defenses that make raw honey a non-issue for eating. Medical-grade honey products address this through gamma irradiation, a sterilization step that eliminates spores and other contaminants while preserving most of the honey’s antibacterial compounds. This is the same general logic separating raw from commercially processed honey discussed in this site’s raw vs. processed honey guide, taken to a clinical standard: a finished product tested and cleared for use on broken skin, not just filtered or pasteurized for shelf stability.
FDA Clearance: What the Record Actually Shows
Derma Sciences’ Medihoney Primary Dressings with Active Manuka Honey received FDA 510(k) clearance on November 7, 2007 (K072956). The clearance letter lists the device’s regulatory class as "Unclassified" under product code FRO, cleared through the substantial-equivalence pathway rather than as a novel device requiring premarket approval. Its predicate was an earlier honey wound dressing from the same company, the API-MED Active Manuka Honey Absorbent Dressing (K053095), cleared several months earlier in July 2007 — making that the actual first FDA clearance of a honey-based wound product, with the Medihoney-branded Primary Dressings following it into the same product line within the year. Either way, 2007 is the real milestone: it is when a standardized, sterilized honey product first met the FDA’s substantial-equivalence bar for wound management, a meaningfully higher and more rigorously documented bar than the largely unregulated supplement category most other honey-based health products fall into, discussed more broadly in this site’s coverage of propolis and other bee-product supplements. The cleared indications, read directly from the filing, are covered in full below.
What the Clinical Evidence Actually Shows
Clinical research on medical-grade honey is more rigorous than for most other honey health claims on this site, but it is also more mixed than marketing copy usually admits. A 2025 peer-reviewed review in Health Science Reports describes clinical benefit for partial-thickness burns, some surgical-wound outcomes (pain reduction, granulation tissue formation), and a cold-sore trial where l-Mesitran healed lesions in an average of 5.8 days versus 10.0 days for conventional treatment (p<0.0001). For diabetic foot ulcers, the same review cites a trial where honey produced a 45% mean reduction in wound area versus 40% for a gel dressing — a difference the study did not find statistically significant.
The venous-leg-ulcer picture is the one most worth being precise about, because it is the most-cited and the most misread. The largest randomized trial on the question (Jull et al., British Journal of Surgery, 2008; 368 participants) found that 55.6% of honey-treated ulcers had healed at 12 weeks versus 49.7% with usual care — a 5.9-point difference that was not statistically significant (P = 0.258), and honey was associated with significantly more adverse events, mainly application-site pain. The trial’s own conclusion, not a paraphrase, is worth reading directly rather than inferring from the healing percentage alone.
Honey-impregnated dressings did not significantly improve venous ulcer healing at 12 weeks compared with usual care.
That finding is echoed by guideline reviewers, not contradicted by them, as the comparison table below shows.
Raw Honey vs. Medical-Grade Honey vs. Standard Dressings
| Category | Sterilized? | Regulatory status | Typical form | Appropriate for open wounds? |
|---|---|---|---|---|
| Raw / kitchen honey | No — may carry dormant bacterial spores | Food product; not reviewed or cleared as wound care | Jar, as sold for eating | Not recommended beyond a very minor scrape |
| Medical-grade honey (e.g., Medihoney) | Yes — gamma-irradiated | FDA 510(k)-cleared medical device (e.g., K072956) | Impregnated dressings, gels, pastes | Yes, for its cleared indications, as part of a clinician-directed plan |
| Standard hydrocolloid / hydrogel dressings | Yes — manufactured sterile | FDA-cleared medical devices (various clearances) | Sheet, gel, or foam dressings | Yes — first-line for most wounds; no honey-specific antibacterial mechanism of their own |
The table above answers the "is it FDA-cleared" question at the category level; the next one breaks the clinical evidence down by wound type, since that is where medical-grade honey’s case gets meaningfully stronger or weaker.
| Wound type | Evidence strength | What the primary sources actually show |
|---|---|---|
| Partial-thickness burns | Moderate | CADTH’s 2018 guideline review found "evidence of limited quality" suggesting some benefit — the strongest single category in that review |
| Pressure injuries (bedsores) | Guideline-supported, evidence limited | CADTH: topical honey and honey-impregnated dressings "may be considered" for pressure injuries |
| Diabetic foot ulcers | Mixed / inconclusive | 45% vs. 40% wound-area reduction versus a gel dressing comparator; difference not statistically significant |
| Venous leg ulcers | Weak — guideline recommends against | 55.6% vs. 49.7% healed at 12 weeks (P = 0.258, not significant); more adverse events with honey; CADTH-reviewed guideline recommends against use |
| Surgical and donor-site wounds | FDA-cleared indication; supportive evidence | Benefits reported for pain reduction and granulation tissue formation |
| Deep, heavily infected wounds / systemic infection | Not appropriate | Not a substitute for surgical debridement or systemic antibiotic therapy |
Why Honey Works: The Mechanism
Where medical-grade honey does show antibacterial activity, it rests on a few well-documented mechanisms rather than one mysterious property. Its high sugar concentration draws moisture out of bacterial cells by osmosis; many honeys, Manuka included, generate hydrogen peroxide through an enzymatic reaction; and Manuka specifically also contains methylglyoxal, which disrupts bacterial function independently of the hydrogen peroxide pathway. Its naturally low pH and ability to keep a wound bed moist round out the profile. Potency varies a great deal by floral source — which is also why other antibacterial honeys, like the one covered in this site’s guide to Jarrah honey, get evaluated on the same basic criteria as Manuka rather than assumed equivalent to it.
Where It’s Actually Used in Practice
Read directly from the K072956 indications-for-use statement, Medihoney Primary Dressings are indicated for light-to-moderately-exuding wounds: diabetic foot ulcers; leg ulcers, including venous stasis, arterial, and mixed-etiology ulcers; pressure ulcers and sores of partial and full thickness; 1st- and 2nd-degree partial-thickness burns; and donor sites, traumatic wounds, and surgical wounds. Being a cleared indication does not mean the evidence behind every one of those wound types is equally strong, as the table above shows — it means the FDA accepted the device as substantially equivalent to an already-legal predicate for that use, not that every use has since been validated by a large randomized trial. Veterinary medicine has also adopted similar products for comparable wound types in animals, which is a lower-profile but genuine use case. Products come as impregnated gauze, gels, or pastes, chosen by wound type, depth, and drainage volume.
Where the Evidence Is Weaker or the Product Isn’t Appropriate
Medical-grade honey is not a universal wound-care solution. It is not recommended as primary treatment for deep, heavily infected wounds needing surgical intervention, and it is not a substitute for systemic antibiotic therapy where that is indicated. The 2018 CADTH guideline review found the overall evidence for chronic wounds "inconclusive" outside burns and pressure injuries, and specifically flagged one evidence-based guideline that recommends against honey for chronic wounds, including venous leg ulcers — a recommendation consistent with the Jull trial’s null result above. Application-site stinging or burning, tied to the honey’s acidity and osmotic effect, is a real and fairly common tolerability issue; the 2025 Health Science Reports review also notes that true honey allergy is rare (estimated under 0.001% of people) but can include anaphylaxis, which matters for anyone with a known bee-product allergy. Medical-grade honey is best treated as one evidence-supported option among several, appropriate for specific wound types, not a default first choice or a stand-in for a clinician’s judgment.
Common Mistakes
The most consequential mistake is applying ordinary kitchen honey directly to an open wound at home on the assumption that it is equivalent to a medical-grade product; raw honey has neither the sterilization nor the standardized potency testing that make a cleared product verified safe for that use. A second mistake is treating medical-grade honey as a replacement for professional wound care rather than a tool used within it — these products are typically applied and monitored as part of a clinician-directed plan, especially for chronic or serious wounds. People also sometimes confuse medical-grade wound products with the cosmetic, skin-care honey applications covered in this site’s guide to honey for skin, a genuinely different use case, evidence base, and regulatory category from clinical wound management. Finally, reading a single healing-rate percentage (like 55.6%) without its comparison group and significance level, as much secondary coverage of the venous-ulcer trial does, overstates what that specific trial actually found.
Frequently Asked Questions
Is medical-grade honey the same product as the raw honey sold at a grocery store?
No. Medical-grade honey is gamma-irradiated to eliminate bacterial spores and is standardized for a verified level of antibacterial activity, then packaged as a sterile dressing, gel, or paste. Raw honey is neither sterilized nor standardized to a clinical specification, which is why it is not considered equivalent for wound use.
Can I use regular honey from my pantry on a cut or wound at home?
This is not recommended beyond a very minor scrape. Raw honey is not sterilized or potency-tested the way medical-grade products are, and open wounds bypass protections that make raw honey a non-issue when eaten. For anything requiring active wound management, a genuine medical-grade product or professional care is the appropriate choice.
Is medical-grade honey regulated as a drug or a medical device?
It is regulated as a medical device. Medihoney’s Primary Dressings were cleared under FDA 510(k) K072956 with regulatory class listed as "Unclassified" and product code FRO, cleared as substantially equivalent to an existing wound dressing rather than reviewed as a drug.
Does the research support using it for venous leg ulcers specifically?
Not strongly. The largest randomized trial (368 patients) found 55.6% of honey-treated ulcers healed at 12 weeks versus 49.7% with usual care, a difference that was not statistically significant, with more adverse events in the honey group. A 2018 guideline review reflects this by recommending against honey for chronic wounds, including venous leg ulcers.
What wound types is medical-grade honey actually FDA-cleared for?
Per the K072956 filing, Medihoney’s Primary Dressings are indicated for diabetic foot ulcers, venous/arterial/mixed-etiology leg ulcers, partial- and full-thickness pressure ulcers, 1st- and 2nd-degree partial-thickness burns, and donor-site, traumatic, and surgical wounds, for light-to-moderately-exuding presentations.
Why does antibiotic resistance come up in discussions of medical-grade honey?
Honey’s antibacterial mechanisms — osmotic dehydration, hydrogen peroxide production, and methylglyoxal in Manuka honey — work through different pathways than conventional antibiotics, so bacteria have not developed the same resistance to it. That makes it a genuinely interesting complementary option as antibiotic-resistant infections become more common in wound care.
Are there side effects from using medical-grade honey on a wound?
The most common issue is temporary stinging or burning on application, related to the honey’s acidity and osmotic effect. True allergy is rare (estimated under 0.001% of people) but can include anaphylaxis in someone with a known bee-product allergy, which is why clinician oversight matters even for a device-grade product.
How does a clinician decide whether to try it on a particular wound?
The decision weighs wound type and depth, response to prior treatments, infection risk and antibiotic-resistance concerns, and patient tolerance for the mild stinging some people experience. It is generally considered one option among several evidence-based dressings available, not a default first choice for every wound.
